Key Statistics
Market Cap$340.07M
P/E Ratio137.6
Div. Yield—
EPS (TTM)$0.07
52W High$18.23
52W Low$8.12
SectorHEALTHCARE
IndustryMEDICAL DEVICES
Employees156
Price Performance
1 Week+7.36%
3 Month-6.14%
1 Year-19.75%
FinancialsAnnual · QuiverQuant
Revenue$2.06M
Assets$38.61M
Liabilities$22.84M
Net Income$47.68M loss
About
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze DCTH with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.